To become a "blockbuster," it must meet efficacy (big mean body weight loss), tolerability (fewer side effects), and something unique, such as dosing convenience (oral delivery and once-a-month shot)
Yes, thats why our abstract title asks, Too much of a good thing? When Im talking to patients about going on these drugs, theyre like, I dont want to go on another medicine. I say, You know what
In various cancer cell lines, such as MDA-MB-231 human breast cancer, prostate cancer (PC3, DU145, LNCaP), and prognostic colon cancer (Ki-67) cells, cannabinoids have demonstrated the ability to downregulate key cell cycle regulatory proteins and inhibit cell cycle progression, leading to reduced cell proliferation [55,59,60,61]
For a more editorial, shorter read on the same protocol, see my piece on drworldwide.com: After the Operating Room: The Peptide Stack My Patients Recover On